637 Bidirectional Gut-Skin Axis
in understanding how these microbial proteins affect host physiological processes and
immune responses. As a result, proteomics provides essential insights into the functional
roles of microbiome-derived proteins and their impact on host health, complementing
the insights gained from metagenomics and metatranscriptomics. Gel electrophoresis,
protein microarrays and MS are all examples of molecular techniques used to investigate
microbiome proteomics.17
Lastly, lipidomics utilizes analytical chemistry tools and principles to study lipid
structures, molecular species abundance, cell functions and, subsequently, microbial-host
interactions.18 This is possible through the identification and quantification of changes in
lipid signaling, metabolism, trafficking and balance within cells.18 MS, NMR and GC are
all approaches used to explore lipidomics in microbiome studies. When used in conjunction,
these multi-omic approaches provide a comprehensive view of microbiome communities,
including both their composition and the functional roles of individual taxa or groups of
taxa within. Integrating this data enables researchers to gain insight into the dynamics of
entire ecosystems, microbial-host interactions and, overall, supports the formulation and
validation of specific hypotheses, aiming for more robust conclusions.8
THE ESTABLISHED ROLE OF THE GUT-SKIN AXIS IN SKIN CONDITIONS
Research has increasingly demonstrated an association between the gut microbiome and
the skin, elucidating the communication pathway known as the gut-skin axis (Figure 1).
The gut microbiome plays a vital role in the regulation of the immune system by protecting
against exogenous pathogens and priming immunoprotective responses. Therefore, it is
responsible for maintaining homeostasis through communication with multiple tissues and
organs, like the skin.25 Consequently, abnormal levels of commensal bacteria in the gut
microbiome may lead to intestinal dysbiosis, which is associated with an altered immune
response and the pathophysiology of multiple inflammatory diseases, related to the gut and
skin, potentially disrupting cutaneous homeostasis.26
The specific mechanisms of communication between the gut microbiome and the skin involve
the immune system and the neuroendocrine system.25 Beginning with diet, part of the healthy
functioning of the gut microbiome includes the degradation of complex polysaccharides into
metabolites, vitamins and SCFAs, the latter of which directly contribute to maintaining the
integrity of the epithelial barrier.27 Conversely, intestinal dysbiosis—which may be caused by
a multitude of factors—is likely to trigger T lymphocyte (T cell) activation and the disruption
of immunosuppressive cytokines and regulatory T lymphocyte (Treg) cells that function to
maintain microbial homeostasis, thereby increasing systemic inflammation.28,29 Oftentimes,
this causes increased intestinal permeability. The disruption of this epithelial barrier may
allow gut microbes, toxins and other metabolites to enter the bloodstream, further triggering
elevated inflammatory cytokine production and T cell responses locally, systemically, and
in the skin.27 In the skin, this may lead to decreased keratin synthesis, altered epidermal
differentiation and, ultimately, the weakening of the skin barrier.28–30
Therefore, microbial metabolites may influence the gut-skin axis by interacting with skin
receptors, potentially affecting the cutaneous environment.3 The most extensively studied
microbial metabolites are SCFAs, which are aliphatic carboxylic acids with fewer than six
carbon atoms, including butyrate, acetate and propionate.31 These are produced by the
fermentation of undigested polysaccharides by intestinal microbes in the colon, primarily
638 JOURNAL OF COSMETIC SCIENCE
by two anaerobic bacterial phyla: Bacteroidetes and Firmicutes.32 Key genera involved in this
production include Bifidobacterium, Eubacterium, Lactobacillus and Prevotella.33 Roseburia, a
genus within the Lachnospiraceae family, is a key producer of butyrate in the gut.27 These
SCFAs serve critical functions including blood pressure regulation, post-infarction heart
healing, anti-inflammation and gut barrier function by serving as an energy source for
intestinal epithelial cells.34
Varied amounts of SCFAs enter the bloodstream, influenced by factors such as dietary fiber
intake, microbial fermentation rates and the extent of colon absorption. Once absorbed,
SCFAs interact with G-coupled-protein receptors such as free fatty acid receptor 2 (FFAR2,
also known as GPR43), the free fatty acid receptor 3 (FFAR3, also known as GPR41) and
the free fatty acid receptor GPR109a. These are expressed in tissues including adipocytes,
intestinal epithelial cells, pancreatic beta-cells, the spleen and immune cells such as M2
macrophages, neutrophils, eosinophils and mast cells.32,35 Regarding the skin, SCFAs can
dampen immunoglobulin E (IgE) allergic inflammatory responses, increase cholesterol and
ceramide concentrations in the stratum corneum, repress transepidermal water loss for the
maintenance of the epidermal barrier and inhibit histone deacetylation of keratinocytes to
further suppress inflammation.31 Therefore, SCFAs may directly affect the skin or alter the
skin’s commensal bacteria. However, further research is needed to determine the clinically
significant amount of SCFAs that must reach the bloodstream to impact the skin.30
Other gut microbial metabolites associated with skin conditions include tryptophan
metabolites.36 In the gut, commensal colon-inhabiting microbes like Clostridium, Bacteroides,
Bifidobacterium and Lactobacillus convert tryptophan to indole and its derivatives, such as
indole-3-aldehyde (IAId), indole-3-lactic acid (ILA), indole-3-propionic acid (IPA), indole-
3-acetic acid (IAA), indole-3-acrylic acid (IA) and tryptamine, all of which play key roles
in maintaining intestinal immune balance and barrier function.37,38 IPA in specific has
demonstrated the ability of enhancing intestinal barrier function in vitro and murine
models.39 Furthermore, products of this indole pathway, like indole-3-carbaldehyde (I3A),
can activate the aryl hydrocarbon receptor (AhR), which is widely expressed in skin cells
like fibroblasts, keratinocytes, Langerhans cells, melanocytes, sebocytes, mast cells and
lymphocytes.40–45 The effects of AhR stimulation are dependent on the dose and the specific
ligand, influencing different transcriptional pathways and inducing various biological
responses.40 AhR activation in the skin has been shown to enhance the production of key
skin barrier proteins, improving skin hydration and reducing water loss, while also causing
the upregulation of metalloproteinases and suppression of type I collagen and fibronectin
expression, thereby improving wound healing and decreasing scar formation.46 In addition,
another bacterial metabolite of tryptophan is indole pyruvate (IPyr) and it exerts a protective
effect on keratinocytes exposed to UVB.47
Finally, amine derivatives—such as trimethylamine (TMA) and trimethylamine N-oxide
(TMAO) —produced by the gut microbiome have been associated with skin health.36 These
amine derivatives are products of the intestinal microbiome’s degradation of quaternary
amine group-containing molecules, such as choline, L-carnitine or phosphatidylcholine
found in eggs, liver and dairy.48 TMA is generated by bacterial genera such as Clostridium,
Proteus, Shigella and Enterobacter and is then transported to the liver where it is oxidized
to produce TMAO.49 Further research is required to fully understand the implications of
TMA and TMAO in skin health. However, in general, elevated levels of these metabolites
have been associated with skin disorders such as psoriasis, systemic lupus erythematosus
and hidradenitis suppurativa.49–51
Previous Page Next Page